SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cheong-Meng Chong, Mingyun Shen, Zhong-Yan Zhou, Peichen Pan, Pui-Man Hoi, Shang Li, Wang Liang, Nana Ai, Lun-Qing Zhang, Cheuk-Wing Li, Huidong Yu, Tingjun Hou, Simon Ming-Yuen Lee, Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP+-induced oxidative stress and cell death in SH-SY5Y cells, Free Radical Biology and Medicine, 2014, 74, 283

    CrossRef

  2. 2
    Johanna Mäkelä, Timofey V Tselykh, Francesca Maiorana, Ove Eriksson, Hai Do, Giuseppa Mudò, Laura T Korhonen, Natale Belluardo, Dan Lindholm, Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1, SpringerPlus, 2014, 3, 1, 2

    CrossRef

  3. 3
    Xiao-Li Wang, Gui-Hua Xing, Bo Hong, Xiao-Ming Li, Yu Zou, Xiao-Jie Zhang, Miao-Xian Dong, Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: Involvement of ERK1/2–Nrf2 signaling pathway, Life Sciences, 2014,

    CrossRef

  4. 4
    Nathalie Dehorter, Constance Hammond, Giant GABAA receptor mediated currents in the striatum, a common signature of Parkinson's disease in pharmacological and genetic rodent models, Basal Ganglia, 2014, 3, 4, 197

    CrossRef

  5. 5
    B. Li, L. Xiao, Z. Y. Wang, P. S. Zheng, Knockdown of STIM1 inhibits 6-hydroxydopamine-induced oxidative stress through attenuating calcium-dependent ER stress and mitochondrial dysfunction in undifferentiated PC12 cells, Free Radical Research, 2014, 48, 7, 758

    CrossRef

  6. 6
    Galba Beppe, Alain Dongmo, Harquin Foyet, Nolé Tsabang, Zenovia Olteanu, Oana Cioanca, Monica Hancianu, Théophile Dimo, Lucian Hritcu, Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease, BMC Complementary and Alternative Medicine, 2014, 14, 1, 142

    CrossRef

  7. 7
    Pei Zhang, Bo Tian, Metabolic Syndrome: An Important Risk Factor for Parkinson’s Disease, Oxidative Medicine and Cellular Longevity, 2014, 2014, 1

    CrossRef

  8. 8
    Stéphane Fourcade, Jone López-Erauskin, Montserrat Ruiz, Isidre Ferrer, Aurora Pujol, Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy, Biochimie, 2014, 98, 143

    CrossRef

  9. 9
    Vipan K. Parihar, Junaid Pasha, Katherine K. Tran, Brianna M. Craver, Munjal M. Acharya, Charles L. Limoli, Persistent changes in neuronal structure and synaptic plasticity caused by proton irradiation, Brain Structure and Function, 2014,

    CrossRef

  10. 10
    Virginie Licker, Pierre R. Burkhard, Proteomics as a new paradigm to tackle Parkinson’s disease research challenges, Translational Proteomics, 2014,

    CrossRef

  11. 11
    Justine Renaud, Julie Bournival, Ximena Zottig, Maria-Grazia Martinoli, Resveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization, Neurotoxicity Research, 2014, 25, 1, 110

    CrossRef

  12. 12
    Mei-Li Díaz-Hung, Lisette Blanco, Nancy Pavón, Rilda León, Bárbara Estupiñan, Eduardo Orta, Klaudia Martínez, Isabel Fernández, Sensory-motor performance after acute glutathione depletion by l-buthionine sulfoximine injection into substantia nigra pars compacta, Behavioural Brain Research, 2014, 271, 286

    CrossRef

  13. 13
    Behrang Alani, Rasoul Salehi, Payam Sadeghi, Mohammad Zare, Fariba Khodagholi, Ehsan Arefian, Mazdak Ganjalikhani Hakemi, Hadi Digaleh, Silencing of Hsp90 Chaperone Expression Protects Against 6-Hydroxydopamine Toxicity in PC12 Cells, Journal of Molecular Neuroscience, 2014, 52, 3, 392

    CrossRef

  14. 14
    Eugenia Yakunin, Haya Kisos, Willem Kulik, Jessica Grigoletto, Ronald J. A. Wanders, Ronit Sharon, The regulation of catalase activity by PPAR γ is affected by α-synuclein, Annals of Clinical and Translational Neurology, 2014, 1, 3
  15. 15
    Rituraj Niranjan, The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes, Molecular Neurobiology, 2014, 49, 1, 28

    CrossRef

  16. 16
    Ming Lu, Xiu-Lan Sun, Chen Qiao, Yang Liu, Jian-Hua Ding, Gang Hu, Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation, Neurobiology of Aging, 2014, 35, 2, 421

    CrossRef

  17. 17
    Mikhail S. Shchepinov, Vitaly A. Roginsky, J. Thomas Brenna, Robert J. Molinari, Randy To, Hui Tsui, Catherine F. Clarke, Amy B. Manning-Boğ, Omega-3 Fatty Acids in Brain and Neurological Health, 2014,

    CrossRef

  18. 18
    Jereme G. Spiers, Hsiao-Jou Chen, Adrian J. Bradley, Stephen T. Anderson, Conrad Sernia, Nickolas A. Lavidis, Acute restraint stress induces rapid and prolonged changes in erythrocyte and hippocampal redox status, Psychoneuroendocrinology, 2013, 38, 11, 2511

    CrossRef

  19. 19
    Erwan Bezard, Zhenyu Yue, Deniz Kirik, Maria Grazia Spillantini, Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies, Movement Disorders, 2013, 28, 1
  20. 20
    Jin-Sun Heo, Jong-Won Choi, Anti-epilepsy Effect of Methanol Extract of Morinda officinalis Augments Pentylenetetrazol-Induced Convulsion Behaviors, Korean Journal of Plant Resources, 2013, 26, 1, 44

    CrossRef

  21. 21
    Hai-Yan Gui, Rui-Ni Chen, Yan Peng, Jin-Hua Hu, Zhao Mao, Rui Ning, Wei Shang, Wei Liu, Jing Xiong, Gang Hu, Jian Yang, Curcumin Protects against 1-Methyl-4-phenylpyridinium Ion- and Lipopolysaccharide-Induced Cytotoxicities in the Mouse Mesencephalic Astrocyte via Inhibiting the Cytochrome P450 2E1, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  22. 22
    Yi-Chun Chen, Yih-Ru Wu, Yi-Ci Wu, Guey-Jen Lee-Chen, Chiung-Mei Chen, Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 2, 247

    CrossRef

  23. 23
    Karamkolly R. Rekha, Govindasamy P. Selvakumar, Karunanithi Santha, Ramu Inmozhi Sivakamasundari, Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner, Biochemical and Biophysical Research Communications, 2013, 440, 4, 664

    CrossRef

  24. 24
    Li Gao, Jian-Song Fang, Xiao-Yu Bai, Dan Zhou, Yi-Tao Wang, Ai-Lin Liu, Guan-Hua Du, In silico Target Fishing for the Potential Targets and Molecular Mechanisms of Baicalein as an Antiparkinsonian Agent: Discovery of the Protective Effects on NMDA Receptor-Mediated Neurotoxicity, Chemical Biology & Drug Design, 2013, 81, 6
  25. 25
    Christian T. Sheline, Julia Zhu, Wendy Zhang, Chunxiao Shi, Ai-Li Cai, Mitochondrial Inhibitor Models of Huntington’s Disease and Parkinson’s Disease Induce Zinc Accumulation and Are Attenuated by Inhibition of Zinc Neurotoxicity in vitro or in vivo, Neurodegenerative Diseases, 2013, 11, 1, 49

    CrossRef

  26. 26
    Stéphanie Simoni, Dominique Linard, Emmanuel Hermans, Bernard Knoops, Julie Goemaere, Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death, Journal of Neurochemistry, 2013, 125, 3
  27. 27
    Anna R. Carta, Augusta Pisanu, Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?, Neurotoxicity Research, 2013, 23, 2, 112

    CrossRef

  28. 28
    Monica Hancianu, Oana Cioanca, Marius Mihasan, Lucian Hritcu, Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats, Phytomedicine, 2013, 20, 5, 446

    CrossRef

  29. You have free access to this content29
    Sudhakar R. Subramaniam, Elizabeth M. Ellis, Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease, Journal of Neuroscience Research, 2013, 91, 3
  30. 30
    Peizhong Mao, Charles Meshul, Philippe Thuillier, P. Reddy, Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease, Pharmaceuticals, 2013, 6, 1, 108

    CrossRef

  31. 31
    Sarah Ciccone, Emiliano Maiani, Giovanna Bellusci, Marc Diederich, Stefania Gonfloni, Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress, International Journal of Molecular Sciences, 2013, 14, 2, 2388

    CrossRef

  32. 32
    Gaurav Kumar, Loganathan Karthik, Kokati Vankata Bhaskara Rao, Phytochemical composition and in vitro antioxidant activity of aqueous extract of Aerva lanata (L.) Juss. ex Schult. Stem (Amaranthaceae), Asian Pacific Journal of Tropical Medicine, 2013, 6, 3, 180

    CrossRef

  33. 33
    Renata Pietsch Ribeiro, Eduardo Luiz Gasnhar Moreira, Danúbia Bonfanti Santos, Dirleise Colle, Alessandra Antunes Santos, Kaite Cristiane Peres, Claudia Pinto Figueiredo, Marcelo Farina, Probucol Affords Neuroprotection in a 6-OHDA Mouse Model of Parkinson’s Disease, Neurochemical Research, 2013, 38, 3, 660

    CrossRef

  34. 34
    Hyun Soo Kim, Tae Gen Son, Hee Ra Park, Yonghyun Lee, Yunjin Jung, Akihito Ishigami, Jaewon Lee, Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation, Neurobiology of Aging, 2013, 34, 4, 1177

    CrossRef

  35. 35
    Emran Esmaeilzadeh, Mossa Gardaneh, Ehsan Gharib, Farzaneh Sabouni, Shikonin Protects Dopaminergic Cell Line PC12 Against 6-Hydroxydopamine-Mediated Neurotoxicity Via Both Glutathione-Dependent and Independent Pathways and by Inhibiting Apoptosis, Neurochemical Research, 2013, 38, 8, 1590

    CrossRef

  36. 36
    Xudong Xu, Wenming Gao, Shanshan Dou, Baohua Cheng, Simvastatin Inhibited the Apoptosis of PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium Ion via Inhibiting Reactive Oxygen Species Production, Cellular and Molecular Neurobiology, 2013, 33, 1, 69

    CrossRef

  37. 37
    Sebastián Rodríguez, Kazuyuki Uchida, Hiroyuki Nakayama, Striatal TH-immunopositive fibers recover after an intrastriatal injection of 6-hydroxydopamine in golden hamsters treated with prednisolone: Roles of tumor necrosis factor-α and inducible nitric oxide synthase in neurodegeneration, Neuroscience Research, 2013, 76, 1-2, 83

    CrossRef

  38. 38
    Li Zuo, Michael S. Motherwell, The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease, Gene, 2013, 532, 1, 18

    CrossRef

  39. 39
    I. Villanueva, C. Alva-Sánchez, J. Pacheco-Rosado, The Role of Thyroid Hormones as Inductors of Oxidative Stress and Neurodegeneration, Oxidative Medicine and Cellular Longevity, 2013, 2013, 1

    CrossRef

  40. 40
    Ehsan Gharib, Mossa Gardaneh, Sahar Shojaei, Upregulation of Glutathione Peroxidase-1 Expression and Activity by Glial Cell Line–Derived Neurotrophic Factor Promotes High-Level Protection of PC12 Cells Against 6-Hydroxydopamine and Hydrogen Peroxide Toxicities, Rejuvenation Research, 2013, 16, 3, 185

    CrossRef

  41. 41
    Andrzej Bajguz, Agnieszka J. Bajguz, Elzbieta A. Tryniszewska, 2013,

    CrossRef

  42. 42
    Koichi Inoue, Erika Baba, Tomoaki Hino, Hisao Oka, A strategy for high-speed countercurrent chromatography purification of specific antioxidants from natural products based on on-line HPLC method with radical scavenging assay, Food Chemistry, 2012, 134, 4, 2276

    CrossRef

  43. 43
    Jihane Ismaili, Martin Boisvert, Fanny Longpré, Julie Carange, Céline Le Gall, Maria-Grazia Martinoli, Benoit Daoust, Brassinosteroids and analogs as neuroprotectors: Synthesis and structure–activity relationships, Steroids, 2012, 77, 1-2, 91

    CrossRef

  44. 44
    Mehmet Gencer, Selcuk Dasdemir, Bedia Cakmakoglu, Yilmaz Cetinkaya, Figen Varlibas, Hulya Tireli, Cem Ismail Kucukali, Elif Ozkok, Makbule Aydin, DNA Repair Genes in Parkinson's Disease, Genetic Testing and Molecular Biomarkers, 2012, 16, 6, 504

    CrossRef

  45. 45
    M. San Luciano, L. Ozelius, R.B. Lipton, D. Raymond, S.B. Bressman, R. Saunders-Pullman, Gender differences in the IL6 −174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease, Neuroscience Letters, 2012, 506, 2, 312

    CrossRef

  46. 46
    Johnathan Cooper-Knock, Janine Kirby, Laura Ferraiuolo, Paul R. Heath, Magnus Rattray, Pamela J. Shaw, Gene expression profiling in human neurodegenerative disease, Nature Reviews Neurology, 2012, 8, 9, 518

    CrossRef

  47. 47
    Samuel M. Goldman, Freya Kamel, G. Webster Ross, Grace S. Bhudhikanok, Jane A. Hoppin, Monica Korell, Connie Marras, Cheryl Meng, David M. Umbach, Meike Kasten, Anabel R. Chade, Kathleen Comyns, Marie B. Richards, Dale P. Sandler, Aaron Blair, J. William Langston, Caroline M. Tanner, Genetic modification of the association of paraquat and Parkinson's disease , Movement Disorders, 2012, 27, 13
  48. 48
    Silvia A. Mandel, Tali Fishman-Jacob, Moussa B.H. Youdim, Genetic reduction of the E3 ubiquitin ligase element, SKP1A and environmental manipulation to emulate cardinal features of Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S177

    CrossRef

  49. 49
    Margarida Castro-Caldas, Andreia Neves Carvalho, Elsa Rodrigues, Colin Henderson, C. Roland Wolf, Maria João Gama, Glutathione S-Transferase pi Mediates MPTP-Induced c-Jun N-Terminal Kinase Activation in the Nigrostriatal Pathway, Molecular Neurobiology, 2012, 45, 3, 466

    CrossRef

  50. 50
    Chiranjib Chakraborty, Soumen Pal, C. George Priya Doss, Zhi-Hong Wen, Chan-Shing Lin, In Silico Analyses of COMT, an Important Signaling Cascade of Dopaminergic Neurotransmission Pathway, for Drug Development of Parkinson’s Disease, Applied Biochemistry and Biotechnology, 2012, 167, 4, 845

    CrossRef

  51. 51
    Begoña Villar-Cheda, Antonio Dominguez-Meijide, Belen Joglar, Ana I. Rodriguez-Perez, Maria J. Guerra, Jose L. Labandeira-Garcia, Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors, Neurobiology of Disease, 2012, 47, 2, 268

    CrossRef

  52. 52
    Tsukasa Waki, Ikuo Nakanishi, Ken-ichiro Matsumoto, Junichi Kitajima, Toshiyuki Chikuma, Shigeki Kobayashi, Key Role of Chemical Hardness to Compare 2,2-Diphenyl-1-picrylhydrazyl Radical Scavenging Power of Flavone and Flavonol O-Glycoside and C-Glycoside Derivatives, CHEMICAL & PHARMACEUTICAL BULLETIN, 2012, 60, 1, 37

    CrossRef

  53. 53
    María Morán, David Moreno-Lastres, Lorena Marín-Buera, Joaquín Arenas, Miguel A. Martín, Cristina Ugalde, Mitochondrial respiratory chain dysfunction: Implications in neurodegeneration, Free Radical Biology and Medicine, 2012, 53, 3, 595

    CrossRef

  54. 54
    Hui-Ming Gao, Hui Zhou, Jau-Shyong Hong, NADPH oxidases: novel therapeutic targets for neurodegenerative diseases, Trends in Pharmacological Sciences, 2012, 33, 6, 295

    CrossRef

  55. 55
    Wu-Fu Chen, Chiranjib Chakraborty, Chun-Sung Sung, Chien-Wei Feng, Yen-Hsuan Jean, Yen-You Lin, Han-Chun Hung, Tzu-Yi Huang, Shi-Ying Huang, Thung-Ming Su, Ping-Jyun Sung, Jyh-Horng Sheu, Zhi-Hong Wen, Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: a promising candidate for the treatment of Parkinson’s disease, Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385, 3, 265

    CrossRef

  56. 56
    Catarina Pimentel, Liliana Batista-Nascimento, Claudina Rodrigues-Pousada, Regina A. Menezes, Oxidative Stress in Alzheimer's and Parkinson's Diseases: Insights from the YeastSaccharomyces cerevisiae, Oxidative Medicine and Cellular Longevity, 2012, 2012, 1

    CrossRef

  57. 57
    J. Lopez-Erauskin, J. Galino, P. Bianchi, S. Fourcade, A. L. Andreu, I. Ferrer, C. Munoz-Pinedo, A. Pujol, Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy, Brain, 2012, 135, 12, 3584

    CrossRef

  58. 58
    T. Tuon, S.S. Valvassori, J. LOPES-BORGES, T. Luciano, C.B. Trom, L.A. Silva, J. Quevedo, C.T. Souza, F.S. Lira, R.A. Pinho, Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson’s disease, Neuroscience, 2012, 227, 305

    CrossRef

  59. 59
    Marc G. Weisskopf, Paul Knekt, Eilis J. O'Reilly, Jukka Lyytinen, Antti Reunanen, Francine Laden, Larisa Altshul, Alberto Ascherio, Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk, Movement Disorders, 2012, 27, 13
  60. 60
    Julie Bournival, Marc-André Francoeur, Justine Renaud, Maria-Grazia Martinoli, Quercetin and Sesamin Protect Neuronal PC12 Cells from High-Glucose-Induced Oxidation, Nitrosative Stress, and Apoptosis, Rejuvenation Research, 2012, 15, 3, 322

    CrossRef

  61. 61
    Sushruta Koppula, Hemant Kumar, Sandeep Vasant More, Byung Wook Kim, In Su Kim, Dong-Kug Choi, Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease, International Journal of Molecular Sciences, 2012, 13, 12, 10608

    CrossRef

  62. 62
    Sushruta Koppula, Hemant Kumar, Sandeep Vasant More, Hyung-Woo Lim, Soon-Min Hong, Dong-Kug Choi, Recent Updates in Redox Regulation and Free Radical Scavenging Effects by Herbal Products in Experimental Models of Parkinson’s Disease, Molecules, 2012, 17, 12, 11391

    CrossRef

  63. 63
    B.A. Morrow, R.H. Roth, D.E. Redmond, S. Diano, J.D. Elsworth, Susceptibility to a parkinsonian toxin varies during primate development, Experimental Neurology, 2012, 235, 1, 273

    CrossRef

  64. 64
    Francieli J. Rockenbach, Marion Deon, Daiane P. Marchese, Vanusa Manfredini, Caroline Mescka, Graziela S. Ribas, Clarissa T. Habekost, Claudio G. Castro, Laura B. Jardim, Carmen R. Vargas, The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy, Molecular Genetics and Metabolism, 2012, 106, 2, 231

    CrossRef

  65. 65
    A. Anandhan, U. Janakiraman, T. Manivasagam, Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson’s disease, Neuroscience, 2012, 218, 257

    CrossRef

  66. 66
    Colette T. Dooley, Ling Li, Jaime A. Misler, Jane H. Thompson, Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux, Cell Biology and Toxicology, 2012, 28, 2, 89

    CrossRef

  67. 67
    Giuseppa Mudò, Johanna Mäkelä, Valentina Di Liberto, Timofey V. Tselykh, Melania Olivieri, Petteri Piepponen, Ove Eriksson, Annika Mälkiä, Alessandra Bonomo, Minna Kairisalo, Jose A. Aguirre, Laura Korhonen, Natale Belluardo, Dan Lindholm, Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease, Cellular and Molecular Life Sciences, 2012, 69, 7, 1153

    CrossRef

  68. 68
    Dominik Pöltl, Stefan Schildknecht, Christiaan Karreman, Marcel Leist, Uncoupling of ATP-depletion and cell death in human dopaminergic neurons, NeuroToxicology, 2012, 33, 4, 769

    CrossRef

  69. 69
    Fabiola Domínguez, Angel Alonso-Castro, Ma González-Trujano, Adrián Martínez-Cervantes, Hermelinda Salgado-Ceballos, Sergio Torres-Castillo, Sandra Orozco-Suárez, Medicinal Plants, 2012,

    CrossRef

  70. 70
    In Su Kim, Sushruta Koppula, Byung Wook Kim, Min Dong Song, Ju Yeon Jung, Gwang Lee, Hee Soon Lee, Dong-Kug Choi, A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP+-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling, European Journal of Pharmacology, 2011, 650, 1, 48

    CrossRef

  71. 71
    Ane Korff, Brenda Pfeiffer, Michelle Smeyne, Mehmet Kocak, Ronald F. Pfeiffer, Richard Jay Smeyne, Alterations in glutathione S-transferase pi expression following exposure to MPP+-induced oxidative stress in the blood of Parkinson’s disease patients, Parkinsonism & Related Disorders, 2011, 17, 10, 765

    CrossRef

  72. 72
    Carolina Sanmartín-Suárez, Ramón Soto-Otero, Inés Sánchez-Sellero, Estefanía Méndez-Álvarez, Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants, Journal of Pharmacological and Toxicological Methods, 2011, 63, 2, 209

    CrossRef

  73. 73
    Jone López-Erauskin, Stéphane Fourcade, Jorge Galino, Montserrat Ruiz, Agatha Schlüter, Alba Naudi, Mariona Jove, Manuel Portero-Otin, Reinald Pamplona, Isidre Ferrer, Aurora Pujol, Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy, Annals of Neurology, 2011, 70, 1
  74. 74
    Chiung-Mei Chen, Chih-Hsin Lin, Hsueh-Fen Juan, Fen-Ju Hu, Ya-Chin Hsiao, Hsin-Yi Chang, Chih-Ying Chao, I-Cheng Chen, Li-Ching Lee, Tsu-Wei Wang, Ya-Tang Chen, Yi-Tsun Chen, Guey-Jen Lee-Chen, Yih-Ru Wu, ATP13A2 variability in Taiwanese Parkinson's disease, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011, 156, 6
  75. 75
    M. Xia, M. Bian, Q. Yu, J. Liu, Y. Huang, X. Jin, S. Lu, M. Yu, F. Huang, Cold water stress attenuates dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Acta Biochimica et Biophysica Sinica, 2011, 43, 6, 448

    CrossRef

  76. 76
    Yamaratee Jaisin, Anusorn Thampithak, Benjawan Meesarapee, Piyanee Ratanachamnong, Apichart Suksamrarn, Laddawal Phivthong-ngam, Noppawan Phumala-Morales, Sukumal Chongthammakun, Piyarat Govitrapong, Yupin Sanvarinda, Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis, Neuroscience Letters, 2011, 489, 3, 192

    CrossRef

  77. 77
    Calivarathan Latchoumycandane, Vellareddy Anantharam, Huajun Jin, Anumantha Kanthasamy, Arthi Kanthasamy, Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease, Toxicology and Applied Pharmacology, 2011, 256, 3, 314

    CrossRef

  78. 78
    Alexander L. Berry, Thomas Foltynie, Gene therapy: a viable therapeutic strategy for Parkinson’s disease?, Journal of Neurology, 2011, 258, 2, 179

    CrossRef

  79. 79
    B.A. Morrow, R.H. Roth, D.E. Redmond, J.D. Elsworth, Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease, Neuroscience, 2011, 189, 277

    CrossRef

  80. 80
    Larissa M. Balogh, William M. Atkins, Interactions of glutathione transferases with 4-hydroxynonenal, Drug Metabolism Reviews, 2011, 43, 2, 165

    CrossRef

  81. 81
    Janusz Lipski, Robert Nistico, Nicola Berretta, Ezia Guatteo, Giorgio Bernardi, Nicola B. Mercuri, l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?, Progress in Neurobiology, 2011, 94, 4, 389

    CrossRef

  82. 82
    Mario David Cordero, Manuel de Miguel, Ana María Moreno-Fernández, La disfunción mitocondrial en la fibromialgia y su implicación en la patogénesis de la enfermedad, Medicina Clínica, 2011, 136, 6, 252

    CrossRef

  83. 83
    Hector Flavio Ortega-Arellano, Marlene Jimenez-Del-Rio, Carlos Velez-Pardo, Life Span and Locomotor Activity Modification by Glucose and Polyphenols in Drosophila melanogaster Chronically Exposed to Oxidative Stress-stimuli: Implications in Parkinson’s Disease, Neurochemical Research, 2011, 36, 6, 1073

    CrossRef

  84. 84
    Consiglia Pacelli, Domenico De Rasmo, Anna Signorile, Ignazio Grattagliano, Giuseppe di Tullio, Andria D'Orazio, Beatrice Nico, Giacomo Pietro Comi, Dario Ronchi, Ermanno Ferranini, Domenico Pirolo, Peter Seibel, Susanna Schubert, Antonio Gaballo, Gaetano Villani, Tiziana Cocco, Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011, 1812, 8, 1041

    CrossRef

  85. 85
    Sunil K. George, Yan Jiao, Colin E. Bishop, Baisong Lu, Mitochondrial peptidase IMMP2L mutation causes early onset of age-associated disorders and impairs adult stem cell self-renewal, Aging Cell, 2011, 10, 4
  86. 86
    Lucian Hritcu, Harquin Simplice Foyet, Marius Stefan, Marius Mihasan, Acha Emmanuel Asongalem, Pierre Kamtchouing, Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease, Journal of Ethnopharmacology, 2011, 137, 1, 585

    CrossRef

  87. 87
    Raquel Duran, Francisco J. Barrero, Blas Morales, Juan D. Luna, Manuel Ramirez, Francisco Vives, Oxidative Stress and Aminopeptidases in Parkinson’s Disease Patients with and without Treatment, Neurodegenerative Diseases, 2011, 8, 3, 109

    CrossRef

  88. 88
    Mehmet Ali Cikrikcioglu, Mehmet Hursitoglu, Hafize Erkal, Burcin Erdem Kınas, Juan Sztajzel, Mustafa Cakirca, Aysun Guneri Arslan, Aybala Erek, Gulistan Halac, Tufan Tukek, Oxidative stress and autonomic nervous system functions in restless legs syndrome, European Journal of Clinical Investigation, 2011, 41, 7
  89. 89
    Josef Finsterer, Parkinson's syndrome and Parkinson's disease in mitochondrial disorders, Movement Disorders, 2011, 26, 5
  90. 90
    Stefan Wallner, Gerd Schmitz, Plasmalogens the neglected regulatory and scavenging lipid species, Chemistry and Physics of Lipids, 2011, 164, 6, 573

    CrossRef

  91. 91
    Tadahiro Numakawa, Tomoya Matsumoto, Yumiko Numakawa, Misty Richards, Shigeto Yamawaki, Hiroshi Kunugi, Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration, Journal of Toxicology, 2011, 2011, 1

    CrossRef

  92. 92
    In-Su Kim, Hyun-Myung Ko, Sushruta Koppula, Byung-Wook Kim, Dong-Kug Choi, Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson’s disease, Food and Chemical Toxicology, 2011, 49, 4, 963

    CrossRef

  93. 93
    P. Krumova, E. Meulmeester, M. Garrido, M. Tirard, H.-H. Hsiao, G. Bossis, H. Urlaub, M. Zweckstetter, S. Kugler, F. Melchior, M. Bahr, J. H. Weishaupt, Sumoylation inhibits  -synuclein aggregation and toxicity, The Journal of Cell Biology, 2011, 194, 1, 49

    CrossRef

  94. 94
    Mossa Gardaneh, Mostafa Gholami, Nader Maghsoudi, Synergy Between Glutathione Peroxidase-1 and Astrocytic Growth Factors Suppresses Free Radical Generation and Protects Dopaminergic Neurons against 6-Hydroxydopamine, Rejuvenation Research, 2011, 14, 2, 195

    CrossRef

  95. 95
    Wei Wang, Li-Li Zheng, Fang Wang, Zhuang-Li Hu, Wen-Ning Wu, Jun Gu, Jian-Guo Chen, Tanshinone IIA attenuates neuronal damage and the impairment of long-term potentiation induced by hydrogen peroxide, Journal of Ethnopharmacology, 2011, 134, 1, 147

    CrossRef

  96. 96
    Dayane Pessoa De Araújo, Rodrigo De Freitas Guimarães Lobato, José Rodolfo Lopes De Paiva Cavalcanti, Luis Rafael Leite Sampaio, Paulo Victor Pontes Araújo, Marcia Calheiros Chaves Silva, Kelly Rose Tavares Neves, Marta Maria De França Fonteles, Francisca Clea Florenço De Sousa, Silvania Maria Mendes Vasconcelos, The Contributions Of Antioxidant Activity Of Lipoic Acid In Reducing Neurogenerative Progression Of Parkinson’s Disease: A Review, International Journal of Neuroscience, 2011, 121, 2, 51

    CrossRef

  97. 97
    Marie-Christine Chartier-Harlin, Justus C. Dachsel, Carles Vilariño-Güell, Sarah J. Lincoln, Frédéric Leprêtre, Mary M. Hulihan, Jennifer Kachergus, Austen J. Milnerwood, Lucia Tapia, Mee-Sook Song, Emilie Le Rhun, Eugénie Mutez, Lydie Larvor, Aurélie Duflot, Christel Vanbesien-Mailliot, Alexandre Kreisler, Owen A. Ross, Kenya Nishioka, Alexandra I. Soto-Ortolaza, Stephanie A. Cobb, Heather L. Melrose, Bahareh Behrouz, Brett H. Keeling, Justin A. Bacon, Emna Hentati, Lindsey Williams, Akiko Yanagiya, Nahum Sonenberg, Paul J. Lockhart, Abba C. Zubair, Ryan J. Uitti, Jan O. Aasly, Anna Krygowska-Wajs, Grzegorz Opala, Zbigniew K. Wszolek, Roberta Frigerio, Demetrius M. Maraganore, David Gosal, Tim Lynch, Michael Hutchinson, Anna Rita Bentivoglio, Enza Maria Valente, William C. Nichols, Nathan Pankratz, Tatiana Foroud, Rachel A. Gibson, Faycal Hentati, Dennis W. Dickson, Alain Destée, Matthew J. Farrer, Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease, The American Journal of Human Genetics, 2011, 89, 3, 398

    CrossRef

  98. 98
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  99. 99
    Xiao-Guang Luo, Ji-Juan Zhang, Chao-Dong Zhang, Rong Liu, Lan Zheng, Xi-Jin Wang, Sheng-Di Chen, Jian-Qing Ding, Altered Regulation of CD200 Receptor in Monocyte-Derived Macrophages from Individuals with Parkinson’s Disease, Neurochemical Research, 2010, 35, 4, 540

    CrossRef

  100. 100
    Mohammad Moshahid Khan, Md. Nasrul Hoda, Tauheed Ishrat, Ajmal Ahmad, Mohammad Badruzzaman Khan, Gulrana Khuwaja, Syed Shadab Raza, Mohammed M. Safhi, Fakhrul Islam, Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinsonʼs disease, Behavioural Pharmacology, 2010, 21, 5-6, 563

    CrossRef

  101. 101
    Yuen-Shan Ho, Kwok-Fai So, Raymond Chuen-Chung Chang, Anti-aging herbal medicine—How and why can they be used in aging-associated neurodegenerative diseases?, Ageing Research Reviews, 2010, 9, 3, 354

    CrossRef

  102. 102
    Gary E. Gibson, Anatoly Starkov, John P. Blass, Rajiv R. Ratan, M. Flint Beal, Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 1, 122

    CrossRef

  103. 103
    Mee Sook Hong, Hun-Kuk Park, Jong-Soo Yang, Hi-Joon Park, Seung-Tae Kim, Seung-Nam Kim, Ji-Yeun Park, Jeong Yoon Song, Hyun-Kyung Park, Dae Jean Jo, Sung Wook Park, Dong HwanYun, Ju Yeon Ban, Joo-Ho Chung, Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model, Neurological Research, 2010, 32, Supplement-1, 74

    CrossRef

  104. 104
    Juan Xie, Lei Duan, Xia Qian, Xu Huang, Jianhua Ding, Gang Hu, KATP channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production, Journal of Neuroscience Research, 2010, 88, 2
  105. 105
    Konstanze F. Winklhofer, Christian Haass, Mitochondrial dysfunction in Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 1, 29

    CrossRef

  106. 106
    Ana I. Rojo, Nadia G. Innamorato, Ana M. Martín-Moreno, María L. De Ceballos, Masayuki Yamamoto, Antonio Cuadrado, Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease, Glia, 2010, 58, 5
  107. 107
    Shigeki Kobayashi, Tsukasa Waki, Ikuo Nakanishi, Ken-ichiro Matsumoto, Kazunori Anzai, Potent 2,2-Diphenyl-1-picrylhydrazyl Radical-Scavenging Activity of Novel Antioxidants, Double-Stranded Tyrosine Residues Conjugating Pyrocatechol, CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58, 11, 1442

    CrossRef

  108. 108
    Eduardo L. G. Moreira, Daniel Rial, Aderbal S. Aguiar, Cláudia P. Figueiredo, Jarbas M. Siqueira, Silvia DalBó, Heros Horst, Jade de Oliveira, Gianni Mancini, Tiago S. dos Santos, Jardel G. Villarinho, Francielle V. Pinheiro, José Marino-Neto, Juliano Ferreira, Andreza F. De Bem, Alexandra Latini, Moacir G. Pizzolatti, Rosa M. Ribeiro-do-Valle, Rui D. S. Prediger, Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease, Journal of Neural Transmission, 2010, 117, 12, 1337

    CrossRef

  109. You have free access to this content109
    Anna Martínez, Manuel Portero-Otin, Reinald Pamplona, Isidre Ferrer, Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates, Brain Pathology, 2010, 20, 2
  110. 110
    Krystle J. McLaughlin, Claire M. Strain-Damerell, Kefang Xie, Dimitris Brekasis, Alexei S. Soares, Mark S.B. Paget, Clara L. Kielkopf, Structural Basis for NADH/NAD+ Redox Sensing by a Rex Family Repressor, Molecular Cell, 2010, 38, 4, 563

    CrossRef

  111. 111
    J. Infante, I. García-Gorostiaga, P. Sánchez-Juan, M. Sierra, J. L. Martín-Gurpegui, J. Terrazas, I. Mateo, E. Rodríguez-Rodríguez, J. Berciano, O. Combarros, Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson’s disease, European Journal of Neurology, 2010, 17, 5
  112. 112
    M. Jimenez-Del-Rio, C. Guzman-Martinez, C. Velez-Pardo, The Effects of Polyphenols on Survival and Locomotor Activity in Drosophila melanogaster Exposed to Iron and Paraquat, Neurochemical Research, 2010, 35, 2, 227

    CrossRef

  113. 113
    Daisuke Yasokawa, Hitoshi Iwahashi, Toxicogenomics using yeast DNA microarrays, Journal of Bioscience and Bioengineering, 2010, 110, 5, 511

    CrossRef

  114. 114
    Marlene Jimenez-Del-Rio, Gerson Suarez-Cedeño, Carlos Velez-Pardo, Using paraquat to generate anion free radicals and hydrogen peroxide in in vitro: Antioxidant effect of vitamin E, Biochemistry and Molecular Biology Education, 2010, 38, 2
  115. 115
    S. Fourcade, M. Ruiz, C. Guilera, E. Hahnen, L. Brichta, A. Naudi, M. Portero-Otin, G. Dacremont, N. Cartier, R. Wanders, S. Kemp, J. L. Mandel, B. Wirth, R. Pamplona, P. Aubourg, A. Pujol, Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy, Human Molecular Genetics, 2010, 19, 10, 2005

    CrossRef

  116. 116
    Cristofol Vives-Bauza, Maja Tocilescu, Rosa L.A. deVries, Dana M. Alessi, Vernice Jackson-Lewis, Serge Przedborski, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  117. 117
    In Su Kim, Sushruta Koppula, Pyo-Jam Park, Ee Hwa Kim, Chan Gil Kim, Wahn Soo Choi, Kwang Ho Lee, Dong-Kug Choi, Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity, Journal of Ethnopharmacology, 2009, 126, 3, 447

    CrossRef

  118. 118
    C. Y. Chung, J. B. Koprich, P. J. Hallett, O. Isacson, Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression, Proceedings of the National Academy of Sciences, 2009, 106, 52, 22474

    CrossRef

  119. 119
    Baohua Cheng, Xinxin Yang, Liangxiang An, Bo Gao, Xia Liu, Shuwei Liu, Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease, Brain Research, 2009, 1286, 25

    CrossRef

  120. 120
    Silvia Bolognin, Luigi Messori, Paolo Zatta, Metal Ion Physiopathology in Neurodegenerative Disorders, NeuroMolecular Medicine, 2009, 11, 4, 223

    CrossRef

  121. 121
    Desmond J. Smith, Mitochondrial dysfunction in mouse models of Parkinson’s disease revealed by transcriptomics and proteomics, Journal of Bioenergetics and Biomembranes, 2009, 41, 6, 487

    CrossRef

  122. 122
    Ari Nowacek, Lisa M Kosloski, Howard E Gendelman, Neurodegenerative disorders and nanoformulated drug development, Nanomedicine, 2009, 4, 5, 541

    CrossRef

  123. You have full text access to this Open Access content123
    Emma Deas, Helene Plun-Favreau, Nicholas W. Wood, PINK1 function in health and disease, EMBO Molecular Medicine, 2009, 1, 3
  124. 124
    Nicoletta Schintu, Lucia Frau, Marcello Ibba, Arianna Garau, Ezio Carboni, Anna R. Carta, Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease, Neurotoxicity Research, 2009, 16, 2, 127

    CrossRef

  125. 125
    Stefan Schildknecht, Dominik Pöltl, Daniel M. Nagel, Florian Matt, Diana Scholz, Julie Lotharius, Nathalie Schmieg, Alberto Salvo-Vargas, Marcel Leist, Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells, Toxicology and Applied Pharmacology, 2009, 241, 1, 23

    CrossRef

  126. 126
    Maria Grazia Spillantini, Introduction to α-Synucleinopathies,
  127. 127
    Hideko Sone, Hiromi Akanuma, Oxidative Stress-Mediated Signaling Pathways by Environmental Stressors,